Document Detail


Anti-progesterone effects on maternal recognition and behaviour imprinted during first pregnancy in mice.
MedLine Citation:
PMID:  7490563     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Anti-progesterone treatment using specific anti-progesterone antibodies or a progesterone receptor (PR) antagonist during first pregnancy impairs postpartum maternal behaviour in mice. This effect is demonstrable only if the treatment is given during pregnancy but not immediately after parturition. The purpose of the present studies was to investigate if maternal behaviour is also impaired by anti-progesterone treatment in subsequent pregnancies. Studies with a monoclonal antibody to progesterone (DB3; 4.5 nmol/mouse) showed that injection of females on day 17 of second pregnancy did not cause maternal rejection but the latency of pup retrieval was prolonged especially during the first 3 days of lactation. This phenomenon was not observed in animals that had previous experience of full length lactation. Experiments were carried out with mifepristone (RU486; 10 micrograms/mouse) injected at day 17 of first, second or third pregnancies. Pup rejection (22.5% vs 12.3%) and prolongation of the retrieval latency (62.3 +/- 13.3 vs 19.7 +/- 6.5 s; P < 0.02) were observed following the first pregnancy. No abnormal behavioural effects were found in mothers treated in second or third pregnancy who had prior full length lactation experience. Control females subjected to only one pup retrieval test after first delivery rejected their pups if treated in their second pregnancy (27.3% vs 4.4%; P < 0.001) and displayed a marginal prolongation of the retrieval latency period (20.9 +/- 7.0 vs 7.4 +/- 2.6 s). Anti-progesterone treatment had no negative influence when administered during third pregnancy.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
D L Crombie; J S Hayes; R B Heap; M W Wang
Related Documents :
7408783 - The effect of estrogen on fetal survival in progesterone-treated ovariectomized rats.
24863523 - Temporal variation in soluble human leukocyte antigen-g (shla-g) and pregnancy-associat...
7325473 - Toxoplasmosis associated with abortion in goats and sheep in connecticut.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of endocrinology     Volume:  147     ISSN:  0022-0795     ISO Abbreviation:  J. Endocrinol.     Publication Date:  1995 Nov 
Date Detail:
Created Date:  1996-01-04     Completed Date:  1996-01-04     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  0375363     Medline TA:  J Endocrinol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  331-7     Citation Subset:  IM    
Affiliation:
Ligand Pharmaceuticals Inc, San Diego, California 92121, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antibodies, Monoclonal / administration & dosage*
Behavior, Animal / drug effects*
Female
Hormone Antagonists / pharmacology
Immunization, Passive
Lactation / physiology
Maternal Behavior / drug effects*
Mice
Mice, Inbred BALB C
Mifepristone / pharmacology
Pregnancy
Progesterone / antagonists & inhibitors,  immunology,  physiology*
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Hormone Antagonists; 57-83-0/Progesterone; 84371-65-3/Mifepristone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The role of intracerebral insulin in the effect of nutrition on gonadotrophin secretion in mature ma...
Next Document:  Differential expression of vascular endothelial growth factor and its receptor mRNAs in the mouse ut...